TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall.
Antibodies, Monoclonal
/ immunology
Antibody Specificity
Biomarkers, Tumor
/ analysis
Cross Reactions
DNA Nucleotidylexotransferase
/ analysis
Female
Humans
Immunohistochemistry
Italy
Male
Mediastinal Neoplasms
/ enzymology
Neoplasms, Germ Cell and Embryonal
/ enzymology
Ovarian Neoplasms
/ enzymology
Predictive Value of Tests
Reproducibility of Results
Testicular Neoplasms
/ enzymology
differential diagnosis
genital system
germinal cell tumor
haematopoietic
seminoma
tdt
terminal deoxynucleotidyl transferase
Journal
Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
10
01
2019
revised:
12
04
2019
accepted:
13
04
2019
pubmed:
6
5
2019
medline:
30
7
2019
entrez:
6
5
2019
Statut:
ppublish
Résumé
Very recent papers proposed a possible role for the expression of terminal deoxynucleotidyl transferase (TdT) in the tumourigenesis of gonadal and extragonadal germ cell-derived tumours (GCTs). Our multicentric study evaluated the magnitude of the immunoreactivity for TdT in GCTs, encompassing seminoma, dysgerminoma, mature teratoma and mixed GCTs. The histological series was stained with both monoclonal and polyclonal antibodies, yielding a positivity of 80% of cases with well-defined nuclear reactivity. A significant difference in staining intensity between monoclonal and polyclonal antibodies was observed (p=0.005). However, exploiting western blot and more innovative proteomic approaches, no clear-cut evidence of the TdT protein was observed in the neoplastic tissues of the series. Alternatively to the pathogenetic link between TdT expression and GCTs tumourigenesis, we hypothesised the occurrence of a spurious immunohistochemical nuclear cross-reaction, a well-known phenomenon with important implications and a possible source of diagnostic pitfalls in routine practice for pathologists.
Identifiants
pubmed: 31055472
pii: jclinpath-2019-205713
doi: 10.1136/jclinpath-2019-205713
doi:
Substances chimiques
Antibodies, Monoclonal
0
Biomarkers, Tumor
0
DNA Nucleotidylexotransferase
EC 2.7.7.31
Types de publication
Journal Article
Multicenter Study
Langues
eng
Pagination
536-541Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.